Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q) von Fenaux, Pierre, Giagounidis, Aristoteles, Selleslag, Dominik, Beyne-Rauzy, Odile, Mittelman, Moshe, Muus, Petra, Nimer, Stephen D, Hellström-Lindberg, Eva, Powell, Bayard L, Guerci-Bresler, Agnes, Sekeres, Mikkael A, Deeg, H Joachim, Del Cañizo, Consuelo, Greenberg, Peter L, Shammo, Jamile M, Skikne, Barry, Yu, Xujie, List, Alan F

Volltext

Virus-like structures in human stool von Lecatsas, G, Skikne, M I, Haffejee, I E, Windsor, I W

Volltext

44 The effect of oxotremorine (OXO) on platelet function von Balentine, L.T., Dollinger, T.R., Skikne, M., Stechschulte, D.J.

Volltext

Ultrastructure of the lung in the rat following exposure to crocidolite asbestos and quartz von Miller, K., Webster, I., Handfield, R. I. M., Skikne, M. I.

Volltext

Electron microscopy of lung in niemann-pick disease von Skikne, M. I., Prinsloo, I., Webster, I.

Volltext

The effects of asbestos-cement dust inhalation on baboons von Goldstein, B., Webster, I., Rendall, R.E.G., Skikne, M.I.

Volltext

Chordoid sarcoma of the hand - a case report von Jacobs, G.H., Berson, S.D., Skikne, M.I., Rippey, J.J. & Jacobson, J.N.

Volltext

Electron diffraction patterns of U.I.C.C. asbestos samples von Skikne, M.I., Talbot, J.H., Rendall, R.E.G.

Volltext

The prenatal diagnosis of tay-sachs disease von Lane, A.B., Skikne, M.I. & Jenkins, T.

Volltext

Biochemical studies of the matrix of craniovertebral chordoma and a metastasis von Sweet, M. B. E., Thonar, E. J.‐M. A., Berson, S. D., Skikne, M. I., Immelman, A. R., Kerr, W. A.

Volltext

CC-486 (Oral Azacitidine) Maintenance Therapy Is Well Tolerated after Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) in Patients with Myelodysplastic Syndromes (MDS)... von de Lima, Marcos, MD, Oran, Betul, MD, Papadopoulos, Esperanza B., MD, Scott, Bart L., MD, William, Basem M., MD, Giralt, Sergio A., MD, Champlin, Richard E., MD, Hetzer, Joel, PhD, Tosolini, Alessandra, BSc, Laille, Eric, MS, Skikne, Barry S., MD, Craddock, Charles, MRCP, MRCPath, BM

Volltext

Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care von Döhner, Hartmut, Dolnik, Anna, Tang, Lin, Seymour, John F., Minden, Mark D., Stone, Richard M., del Castillo, Teresa Bernal, Al-Ali, Haifa Kathrin, Santini, Valeria, Vyas, Paresh, Beach, C. L., MacBeth, Kyle J., Skikne, Barry S., Songer, Steve, Tu, Nora, Bullinger, Lars, Dombret, Hervé

Volltext

Extended dosing with CC‐486 (oral azacitidine) in patients with myeloid malignancies von Savona, Michael R., Kolibaba, Kathryn, Conkling, Paul, Kingsley, Edwin C., Becerra, Carlos, Morris, John C., Rifkin, Robert M., Laille, Eric, Kellerman, Amy, Ukrainskyj, Stacey M., Dong, Qian, Skikne, Barry S.

Volltext

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS von List, A F, Bennett, J M, Sekeres, M A, Skikne, B, Fu, T, Shammo, J M, Nimer, S D, Knight, R D, Giagounidis, A

Volltext

Pharmacokinetics and Pharmacodynamics with Extended Dosing of CC-486 in Patients with Hematologic Malignancies von Laille, Eric, Shi, Tao, Garcia-Manero, Guillermo, Cogle, Christopher R, Gore, Steven D, Hetzer, Joel, Kumar, Keshava, Skikne, Barry, MacBeth, Kyle J

Volltext

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission von Wei, Andrew H, Döhner, Hartmut, Pocock, Christopher, Montesinos, Pau, Afanasyev, Boris, Dombret, Hervé, Ravandi, Farhad, Sayar, Hamid, Jang, Jun-Ho, Porkka, Kimmo, Selleslag, Dominik, Sandhu, Irwindeep, Turgut, Mehmet, Giai, Valentina, Ofran, Yishai, Kizil Çakar, Merih, Botelho de Sousa, Aida, Rybka, Justyna, Frairia, Chiara, Borin, Lorenza, Beltrami, Germana, Čermák, Jaroslav, Ossenkoppele, Gert J, La Torre, Ignazia, Skikne, Barry, Kumar, Keshava, Dong, Qian, Beach, C.L, Roboz, Gail J

Volltext

Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer von Babiker, Hani M., Milhem, Mohammed, Aisner, Joseph, Edenfield, William, Shepard, Dale, Savona, Michael, Iyer, Swaminathan, Abdelrahim, Maen, Beach, C. L., Skikne, Barry, Laille, Eric, Tsai, Kao-Tai, Ho, Thai

Volltext

Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-co... von Roboz, Gail J, Döhner, Hartmut, Pocock, Christopher, Dombret, Herve, Ravandi, Farhad, Jang, Jun Ho, Selleslag, Dominik, Mayer, Jiři, Martens, Uwe M, Liesveld, Jane, Bernal, Teresa, Wang, Ming Chung, Yu, Peiwen, Shi, Ling, Guo, Shien, La Torre, Ignazia, Skikne, Barry, Dong, Qian, Braverman, Julia, Nehme, Salem Abi, Beach, C L, Wei, Andrew H

Volltext

CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia von Garcia-Manero, Guillermo, Scott, Bart L., Cogle, Christopher R., Boyd, Thomas E., Kambhampati, Suman, Hetzer, Joel, Dong, Qian, Kumar, Keshava, Ukrainskyj, Stacey M., Beach, CL, Skikne, Barry S.

Volltext

A First-in-Human, Phase 1, Dose Escalation Study of Sgr-2921 As Monotherapy in Subjects with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome von DiNardo, Courtney D., Strickland, Stephen Anthony, Skikne, Barry, Zeidan, Amer M., Traer, Elie, Carraway, Hetty E., Frankel, Stanley, Weiss, Daniel E, Wang, Jacky H, Pirie-Shepherd, Steven, Piccotti, Joseph, Wright, D. Hamish, Akinsanya, Karen

Volltext